Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways

被引:41
|
作者
Gonzalez-Fernandez, Rebeca [2 ]
Pena, Oscar [2 ]
Hernandez, Jairo [1 ]
Martin-Vasallo, Pablo [2 ,3 ]
Palumbo, Angela [1 ,4 ]
Avila, Julio [2 ,3 ]
机构
[1] Ctr Asistencia Reprod Humana Canarias, San Cristobal la Laguna, Spain
[2] Univ La Laguna, Dept Bioquim & Biol Mol, E-38207 San Cristobal la Laguna, Spain
[3] Univ La Laguna, Inst Tecnol Biomed, Tenerife, Spain
[4] NYU, Dept Obstet & Gynecol, New York, NY 10016 USA
关键词
Granulosa-lutein cells; PAPP and CYP19A1 genes; in vitro fertilization; FSHR pathway signaling; RAT GRANULOSA-CELLS; MOLECULAR-BIOLOGY; GENE-EXPRESSION; FSH RECEPTOR; PROTEIN; GROWTH; ACTIVATION; INDUCTION; ESTRADIOL; AROMATASE;
D O I
10.1016/j.fertnstert.2011.03.030
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To study the integrity of the FSH receptor (FSHR) signaling pathway in granulosa-lutein cells at the time of egg retrieval and its relationship with the infertility diagnosis. Design: In vitro assays. Setting: University laboratory and private IVF center. Patient(s): Patients undergoing IVF: 35 controls (no ovarian factor, NOF), 28 poor responders (PR), 32 patients with endometriosis (EM), and 22 patients with polycystic ovary syndrome (PCOS). Intervention(s): Quantitative reverse transcriptase-polymerase chain reaction (PCR) in granulosa-lutein cells from pooled follicles. Main Outcome Measure(s): Correlation between expression of FSHR and FSH-regulated genes PAPP/Cyp19A1. Result(s): Positive correlations among FSHR, PAPP, and Cyp19A1 expression levels are observed in NOF and are lost, with different patterns, in poor responder patients and those with endometriosis. Patients with endometriosis are an heterogeneous group including patients with poor ovarian reserve who behave like other poor responders patients (endometriosis-A) and patients with good response to ovarian stimulation (endometriosis-B) who show a specific alteration of the FSHR signaling pathway. Conclusion(s): These preliminary data suggest that the different signaling pathways activated through the FSHR in normal ovaries (NOF) are disrupted in poor responders and in patients with endometriosis. Abetter knowledge of the molecular origin of these errors may guide clinicians in the choice of personalized ovulation induction protocols for each type of ovarian dysfunction. (Fertil Steril (R) 2011; 95: 2373-8. (C) 2011 by American Society for Reproductive Medicine.)
引用
收藏
页码:2373 / 2378
页数:6
相关论文
共 50 条
  • [21] Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol
    Schoolcraft, W
    Schlenker, T
    Gee, M
    Stevens, J
    Wagley, L
    FERTILITY AND STERILITY, 1997, 67 (01) : 93 - 97
  • [22] Follicle-stimulating hormone receptor gene mutations are not evident in Greek women with premature ovarian failure and poor responders
    Loutradis, D
    Patsoula, E
    Stefanidis, K
    Drakakis, P
    Antonakis, G
    Bletsa, R
    Antsaklis, A
    Michalas, S
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2006, 61 (01) : 56 - 60
  • [23] Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells
    Cai, Jie
    Lou, Hang-ying
    Dong, Min-yue
    Lu, Xiu-e
    Zhu, Yi-min
    Gao, Hui-juan
    Huang, He-feng
    FERTILITY AND STERILITY, 2007, 87 (06) : 1350 - 1356
  • [24] Ovarian hyperstimulation syndrome (OHSS) due to mutations in the follicle-stimulating hormone receptor
    Rodien, P.
    Beau, I.
    Vasseur, C.
    ANNALES D ENDOCRINOLOGIE, 2010, 71 (03) : 206 - 209
  • [25] Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer
    Zhang, Zhenbo
    Jia, Lin
    Feng, Youji
    Zheng, Wenxin
    CANCER LETTERS, 2009, 278 (01) : 56 - 64
  • [26] Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
    Schniewind, Hanna A.
    Sattler, Lisa-Marie
    Haudum, Christoph W.
    Muenzker, Julia
    Minich, Waldemar B.
    Obermayer-Pietsch, Barbara
    Schomburg, Lutz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [27] Endocrine Disruption of the Follicle-Stimulating Hormone Receptor Signaling During the Human Antral Follicle Growth
    Roy, Neena
    Mascolo, Elisa
    Lazzaretti, Clara
    Paradiso, Elia
    D'Alessandro, Sara
    Zareba, Kornelia
    Simoni, Manuela
    Casarini, Livio
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [28] Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients
    Bishop, Lauren A.
    Richter, Kevin S.
    Patounakis, George
    Andriani, Leslie
    Moon, Kimberly
    Devine, Kate
    FERTILITY AND STERILITY, 2017, 108 (06) : 980 - 987
  • [29] Role of follicle-stimulating hormone receptor gene polymorphisms in ovarian responses for patients undergoing IVF/ICSI-ET
    Fang, H.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 557 - 558
  • [30] NOVEL FOLLICLE-STIMULATING HORMONE RECEPTOR MUTATIONS CAUSING OVARIAN DYSGENESIS AND PRIMARY OVARIAN INSUFFICIENCY
    Chen, Lin
    Yi, Hong
    Hu, Jingwen
    Zheng, Xi
    Li, Tin Chiu
    Dong, Zirui
    Chen, Xiaoyan
    FERTILITY AND STERILITY, 2024, 122 (04) : E125 - E125